Midbrain dopamine activity produces regionally localized decision substratesAlejandro Pan Vazquez, Christopher Zimmerman, Brenna McMannon et al.
Modeling rapid neuromodulation in the cortex-basal ganglia-thalamus loopJulia Costacurta, Yu Duan, John Assad et al.
Altered firing and dopamine release in Substantia Nigra dopaminergic neurons induced by exposure to alpha-synuclein oligomers: From patch-clamp to diamond multielectrode arraysValentina Carabelli, Giulia Tomagra, Federico Picollo, Andrea Marcantoni
Anatomofunctional characterization of the tail of the ventral tegmental area (tVTA/RMTg) in miceBenjamin Muller, Pierre-Alexis Derrien, Pierre Hener et al.
Anxiety in Parkinson’s disease: Brainstem neuromodulatory mechanismsAlexia Lantheaume, Nina Schöneberg, Silvia Rodriguez Rozada et al.
Differential expression of Cx36 in the reticulo-thalamic nucleus and hippocampus in a rat model of Parkinson's diseaseAndrea Novakovic, Ljiljana Radovanovic, Jasna Saponjic
Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonismMaria Regoni, Letizia Zanetti, Martina Sevegnani et al.
FoxO1 induced by alpha-synuclein preformed fibrils regulates ROS by expressing antioxidant genes in microgliaJiyeon Na, Hyeguk Ryu, Hyeonwoo Park et al.
Glucocerebrosidase pharmacological chaperones attenuate α-synuclein-induced neurotoxicity in chronic cortico-striatal slicesAntonino Iurato La Rocca, Elisabetta Gerace, Miriam Cerullo et al.
Identification of the striatal molecular landscape in Parkinson’s disease mouse modelsMarta Graziano, Ioannis Mantas, Yuvarani Masarapu et al.
The influence of lateralized retinal stimulation on dopaminergic neuron activity and striatal dopamine releaseMartyna Marzec, Karolina Nowalińska, Magdalena Walczak, Tomasz Błasiak
Local and systemic effects: Intermittent theta burst stimulation ameliorates 6-OHDA-induced Parkinson's disease pathology by modulating purinergic signaling and oxidative stressMilorad Dragic, Milica Zeljkovic Jovanovic, Ivana Stevanovic et al.
Modulation of 5-HT4R affects L-DOPA-induced dyskinesia in unilaterally 6-OHDA lesioned miceDemetra Ballardin, Leila Makrini-Maleville, Alexander Seper et al.
MolBoolean staining reveals high proportion of D2 receptors forming A2A-D2 heteromers in striatal neurons of MPTP-lesioned parkinsonian primatesRafael Rivas-Santisteban, Alberto Jose-Rico, Ana Muñoz et al.
Neural origins of forelimb motor dysfunctions in a mouse model of Parkinson's diseaseAntea Minetti, Francesca Macchi, Alessandra Martello et al.
NF-κB-mediated tolerant phenotype in microglia: Implications for Parkinson’s disease dopaminergic neurodegenerationIrina Freitag, Maider Usandizaga, Paula Martínez-Remedios et al.
Novel viral vectors for cell-type specific overexpression of alpha-synucleinSofía Inés García Moreno, Thomas Steinkellner
P2Y1 receptor participates in dopaminergic neurodegeneration in a rat model of Parkinson’s diseaseRoberta Andrejew, Ágatha Oliveira-Giacomelli, Juliana Baranova et al.
Pharmacological modulation of Nrf2 pathway in alpha-synuclein mouse model of Parkinson’s diseaseMichela Salvadè, Elisa Zianni, Maria Italia et al.
Pharmacological inhibition of BET proteins hampers rotenone-induced oxidative damage in an in vitro model of Parkinson’s diseaseNoemi Martella, Daniele Pensabene, Mayra Colardo et al.
Unveiling the influence of melanin on morphological and functional states of rat brain neurons in a rotenone-induced Parkinson's disease modelMargarit Danielyan, Michael Poghosyan, Anichka Hovsepyan et al.